WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ -- To examine key issues around asymmetries, or inequalities, in communicating health information coming from the growing body of comparative effectiveness research (CER), the National Pharmaceutical Council, the National Health Council and WellPoint are sponsoring a conference, Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making.
With billions of dollars in funding being invested in comparative effectiveness research, patients, providers, payers and other health care decision-makers will have more information than ever before about the safety and effectiveness of treatment options. However, not all stakeholders have equal ability to share information in the current regulatory environment. The conference will facilitate discussion about the information needs of patients, payers and other stakeholders, and how the First Amendment and other legal issues apply. Presenters will share with attendees a proposed ethical framework for communicating CER information.
Who: Confirmed speakers include:
When: Thursday, February 9, 2012, from 9:30 a.m. to 4:30 p.m. The conference will open at 8:30 a.m. for registration and a continental breakfast.
Where: Omni Shoreham Hotel, 2500 Calvert St. NW, Washington, D.C.
Registration is complimentary at http://www.npcnow.org/asym12.
To join the conversation on Twitter, use the hashtag #asym12.
|SOURCE National Pharmaceutical Council|
Copyright©2010 PR Newswire.
All rights reserved